Skip to main content
Signal8

SHARP PHILLIP A

SEC insider (Form 3/4/5 filer). CIK 0001226295. Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY). 2 reported Form 4/5 transactions since Sep 2024; latest on Jan 23, 2025. Located in CAMBRIDGE, MA.

Companies SHARP PHILLIP A has filed insider reports for

  • ALNYLAM PHARMACEUTICALS, INC. (ALNY): Director
SHARP PHILLIP A profile photo

SHARP PHILLIP A

CIK: 0001226295

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (50.0%)

Position reduction

Option Exercises (M)1 (50.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ALNYLAM PHARMACEUTICALS, INC. logo
ALNY

ALNYLAM PHARMACEUTICALS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • ALNYLAM PHARMACEUTICALS, INC. logo
    ALNY

    ALNYLAM PHARMACEUTICALS, INC.

    Jan 23, 2025
    Exercise
    Direct
    11.3K shares at avg. $131.21$1.5M
  • ALNYLAM PHARMACEUTICALS, INC. logo
    ALNY

    ALNYLAM PHARMACEUTICALS, INC.

    Jan 23, 2025
    Sale
    Direct
    11.3K shares at avg. $275.00$3.1M

1-2 of 2